Dr Ben Reynolds

  • Honorary Clinical Senior Lecturer (Undergraduate Medical School)

email: Ben.Reynolds@glasgow.ac.uk

Royal Hospital for Children, 1345, Govan Road, Glasgow, G51 4TF

Import to contacts

Publications

List by: Type | Date

Jump to: 2022 | 2021 | 2020 | 2019
Number of items: 7.

2022

Henderson, S., Ardill, R., Reynolds, B. and Kavanagh, D. (2022) Use of a B-cell depleting regimen for antifactor H autoantibody-mediated membranoproliferative glomerulonephritis in a paediatric patient. BMJ Case Reports, 15(4), e246281. (doi: 10.1136/bcr-2021-246281) (PMID:35444020)

Patterson, J., Jacob, Z. and Reynolds, B. C. (2022) Genetic evaluation of paediatric nephrocalcinosis: phenotype-driven genetic panels reveal a rare diagnosis. Clinical Kidney Journal, 15(4), pp. 812-815. (doi: 10.1093/ckj/sfab279) (PMID:35371448)

Reynolds, B. C., Lamb, A., Jones, C. A., Yadav, P., Tyerman, K. S. and Geddes, C. C. (2022) UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant. Pediatric Nephrology, 37(1), pp. 199-207. (doi: 10.1007/s00467-021-05248-9) (PMID:34383125) (PMCID:PMC8674165)

2021

Dobbie, L. J., Lamb, A., Eskell, L., Ramage, I. J. and Reynolds, B. C. (2021) Thromboprophylaxis in congenital nephrotic syndrome: 15 year experience from a national cohort. Pediatric Nephrology, 36(5), pp. 1183-1194. (doi: 10.1007/s00467-020-04793-z) (PMID:33089377)

2020

Bruce, G., Chaudhury, S. and Reynolds, B. (2020) Bilateral primary renal diffuse large B-cell lymphoma: a rare presentation of paediatric renal disease mimicking juvenile nephronophthisis. BMJ Case Reports, 13(2), e234810. (doi: 10.1136/bcr-2020-234810) (PMID:32675115)

Harkins, V.J. , McAllister, D.A. and Reynolds, B.C. (2020) Shiga-toxin E. coli Hemolytic Uremic Syndrome: review of management and long-term outcome. Current Pediatrics Reports, 8, pp. 16-25. (doi: 10.1007/s40124-020-00208-7)

2019

Maxted, A. P., Dalrymple, R. A., Chisholm, D., McColl, J. , Tse, Y., Christian, M. T. and Reynolds, B. C. (2019) Low dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome. Pediatric Nephrology, 34(5), pp. 855-863. (doi: 10.1007/s00467-018-4172-3) (PMID:30564878) (PMCID:PMC6424916)

This list was generated on Mon Apr 22 13:50:33 2024 BST.
Jump to: Articles
Number of items: 7.

Articles

Henderson, S., Ardill, R., Reynolds, B. and Kavanagh, D. (2022) Use of a B-cell depleting regimen for antifactor H autoantibody-mediated membranoproliferative glomerulonephritis in a paediatric patient. BMJ Case Reports, 15(4), e246281. (doi: 10.1136/bcr-2021-246281) (PMID:35444020)

Patterson, J., Jacob, Z. and Reynolds, B. C. (2022) Genetic evaluation of paediatric nephrocalcinosis: phenotype-driven genetic panels reveal a rare diagnosis. Clinical Kidney Journal, 15(4), pp. 812-815. (doi: 10.1093/ckj/sfab279) (PMID:35371448)

Reynolds, B. C., Lamb, A., Jones, C. A., Yadav, P., Tyerman, K. S. and Geddes, C. C. (2022) UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant. Pediatric Nephrology, 37(1), pp. 199-207. (doi: 10.1007/s00467-021-05248-9) (PMID:34383125) (PMCID:PMC8674165)

Dobbie, L. J., Lamb, A., Eskell, L., Ramage, I. J. and Reynolds, B. C. (2021) Thromboprophylaxis in congenital nephrotic syndrome: 15 year experience from a national cohort. Pediatric Nephrology, 36(5), pp. 1183-1194. (doi: 10.1007/s00467-020-04793-z) (PMID:33089377)

Bruce, G., Chaudhury, S. and Reynolds, B. (2020) Bilateral primary renal diffuse large B-cell lymphoma: a rare presentation of paediatric renal disease mimicking juvenile nephronophthisis. BMJ Case Reports, 13(2), e234810. (doi: 10.1136/bcr-2020-234810) (PMID:32675115)

Harkins, V.J. , McAllister, D.A. and Reynolds, B.C. (2020) Shiga-toxin E. coli Hemolytic Uremic Syndrome: review of management and long-term outcome. Current Pediatrics Reports, 8, pp. 16-25. (doi: 10.1007/s40124-020-00208-7)

Maxted, A. P., Dalrymple, R. A., Chisholm, D., McColl, J. , Tse, Y., Christian, M. T. and Reynolds, B. C. (2019) Low dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome. Pediatric Nephrology, 34(5), pp. 855-863. (doi: 10.1007/s00467-018-4172-3) (PMID:30564878) (PMCID:PMC6424916)

This list was generated on Mon Apr 22 13:50:33 2024 BST.